
Death-associated protein kinase promoter methylation correlates with clinicopathological and prognostic features in nonsmall cell lung cancer patients
Author(s) -
Xiangdong Yang,
Jun Zhang,
Xiao Yu,
Guofeng Zheng,
Fei Zhao,
Xiaojing Jia
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.158197
Subject(s) - methylation , medicine , lung cancer , stage (stratigraphy) , oncology , confidence interval , relative risk , gastroenterology , cancer , biology , gene , paleontology , biochemistry
The objective was to study the correlation between death-associated protein kinase (DAPK) promoter methylation and the clinicopathological and prognostic features in nonsmall cell lung cancer (NSCLC) patients.